Cargando…
Bispecific antibodies targeting CTLA-4: game-changer troopers in cancer immunotherapy
Antibody-based cancer immunotherapy has become a powerful asset in the arsenal against malignancies. In this regard, bispecific antibodies (BsAbs) are a ground-breaking novel approach in the therapy of cancers. Recently, BsAbs have represented a significant advancement in improving clinical outcomes...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333476/ https://www.ncbi.nlm.nih.gov/pubmed/37441075 http://dx.doi.org/10.3389/fimmu.2023.1155778 |